Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Six of Oxford University's distinguished scientists, and four from the Medical Sciences Division, have been elected as Fellows of the Royal Society for their outstanding contributions to science.

© OUI/Greg Smolonski

Image credit: OUI/Greg Smolonski

This year’s Fellows are:

Professor Neil Brockdorff FRS, Wellcome Trust Principal Research Fellow, Department of Biochemistry, University of Oxford.

Professor Vincenzo Cerundolo FMedSci FRS, Director, MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford. The award recognises Professor Cerundolo’s world leading research on T cell immunology, particularly his discoveries on how peptides and lipids are processed and presented to T cells. This research has opened new therapeutic avenues. ‘I am extremely honoured and humbled to be receiving such an important recognition,’ said Professor Cerundolo, ‘I am certain that working in the exciting and vibrant environment of the MRC WIMM and being able to collaborate with so many outstanding colleagues has contributed enormously to this achievement.’ Find out more.

Professor Andrew King FMedSci FRS, Wellcome Trust Principal Research Fellow and Professor of Neurophysiology, Department of Physiology, Anatomy and Genetics, University of Oxford. Find out more.

Professor Dominic Kwiatkowski FMedSci FRS, Head of Parasites and Microbes Programme, Wellcome Sanger Institute and Professor of Genomics and Global Health, University of Oxford. Professor Kwiatkowski said: ‘I am honoured to be elected to the Fellowship of the Royal Society. It is a testimony to the amazing creativity and teamwork that is going on at Sanger and Oxford, and among all our partners in the MalariaGEN network. It is a great privilege to work with colleagues who are so committed to gaining a deep scientific understanding of malaria, not only as a fascinating biological problem, but also as a critical step in reducing the burden of disease in the poorest parts of the world.’

Professor Graham Richards CBE FRS, Chairman and Founder, Oxford Drug Design Ltd and Professor, Department of Chemistry, University of Oxford.

Professor Guy Wilkinson FRS, Professor of Physics, Department of Physics, University of Oxford.

Find out more (University of Oxford)

Similar stories

Oxford University wins prestigious Queen’s Anniversary Prize

Her Majesty The Queen has approved the award of The Queen’s Anniversary Prizes to twenty-one higher and further education institutions, including Oxford University, in the most recent round of the independently reviewed scheme. This prestigious award is the highest national honour available to universities and FE colleges across the UK.

Jenner Institute named Covid Innovation Heroes

The team at the University of Oxford’s Jenner Institute has been celebrated for their global pandemic work by The Oxford Trust’s Covid Innovation Heroes Award­ 2021.

New Research Highlights Importance of Early Years Development on Future Wellbeing

Oxford researchers involved nearly 4,000 children across the UK in three specially developed science lessons to educate pupils about brain development during early childhood. The SEEN (Secondary Education around Early Neurodevelopment) project was commissioned and funded by KindredSquared and is part of a wider drive to increase public understanding of how early experiences can shape the adults we become.

Study reveals ‘stop-eating’ response to DNA damage

A new study from the MRC Weatherall Institute of Molecular Medicine sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.

Fiona Powrie appointed new Deputy Chair of Wellcome’s Board of Governors

Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.